Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Trading Update for 2021

13 Jan 2022 07:00

RNS Number : 2927Y
Steppe Cement Limited
13 January 2022
Β 

13 January 2022

Steppe Cement Ltd

Preliminary Update for the Year ended 31 December 2021

Steppe Cement Limited ("Steppe Cement") recorded good revenue growth in 2021 with positive market conditions for the business. The focus has been on the domestic market where Steppe Cement's market share remains resilient.

The recent changes within the Kazakh Government, as well as the disturbances in the main cities, have not affected the continuous operations of the cement factory.

Steppe Cement recorded revenue for the year ended 31 December 2021 of 36,020 million Tenge ("KZT"), which was 16% higher than the KZT 30,958 million recorded for the previous year. In 2021, cement sales volume was 1,688,544 tonnes, higher than the 1,645,744 tonnes achieved for the previous year. The average price (ex-VAT) for delivered cement was KZT 21,332 per tonne in 2021, representing a 13% increase on the KZT 18,811 per tonne achieved in 2020. The average ex-factory price in 2021 stood at KZT 18,134 per tonne compared to 15,760 in 2020, which represents USD 43 per tonne based on 2021's average exchange rate of USD/KZT 426 vs 413 in 2020. As we were limited by our production, we concentrated in the markets closer to our factory.

In 2021, the cement market consumption in Kazakhstan increased by 23% to 11.6 million tonnes from 9.4 million tonnes in 2020. This unexpectedly big increase in domestic demand has been the consequence of the changing in the withdrawal policy for pension funds. Citizens were allowed, under certain conditions, to allocate money from their pension funds to property or health.

Steppe Cement's local market share was 13.9%. Exports decreased by 57.2% from 202,000 tonnes in 2020 to 86,500 tonnes in 2021. Overall, Kazakhstan imported 0.8 million tonnes of cement (vs 0.6 million tonnes in 2020) and exported 1.6 million tonnes (vs 2.0 million tonnes in 2020).

We have a healthy cash balance and are continuing our capex program to increase the production capacity of the Company by 5% by the summer of 2022.

We are in the period of lowest sales of the year, and the directors do not believe they presently have sufficient visibility on economic matters to make an accurate prediction on demand for 2022.

The full results and audited accounts denominated in USD are expected to be published in May 2022.

Steppe Cement's AIM nominated adviser and broker is RFC Ambrian Limited.

Nominated Adviser contact: Stephen Allen or Andrew Thomson on +61 8 9480 2500.

Broker contact: Charlie Cryer at +44 20 3440 6800

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBJMTTMTMBMRT
Date   Source Headline
7th May 20097:00 amRNSUnderwritten Share Offer Results
24th Apr 20097:00 amRNSAnnual Report
14th Apr 200910:00 amRNSUnderwritten Offer of Shares
14th Apr 20097:31 amRNSPreliminary Results Update
16th Feb 20097:50 amRNSPreliminary Results
8th Jan 20097:02 amRNSDirector Shareholding
6th Jan 20097:00 amRNSHolding(s) in Company
19th Dec 20087:00 amRNSDirector Appointment
29th Oct 20088:00 amRNSSuccessful Commissioning of Line 6
17th Oct 20088:02 amRNSDirector Shareholding
17th Oct 20087:00 amRNSRefinancing of Credit Line
5th Sep 20089:01 amRNSInterim Results - Replacement
5th Sep 20088:16 amRNSInterim Results
19th May 20087:00 amRNSResult of AGM
16th May 20087:00 amRNSResignation of Director
6th May 20087:01 amRNSHolding(s) in Company
21st Apr 20081:55 pmRNSAnnual Report and Accounts
16th Apr 20087:00 amRNSFinal Results
21st Dec 20077:00 amRNSDirector/PDMR Shareholding
22nd Nov 20077:01 amRNSDirector/PDMR Shareholding
7th Sep 20077:00 amRNSCorrection to Interim Results
5th Sep 200711:46 amRNSInterim Results
24th Aug 20077:00 amRNSHolding(s) in Company
20th Aug 20078:22 amRNSAIM Rule 26 Information
20th Aug 20078:13 amRNSHolding(s) in Company
7th Aug 20077:00 amRNSNew Significant Shareholder
16th Jul 20079:11 amRNSHolding(s) in Company
5th Jul 20078:01 amRNSDirector/PDMR Shareholding
2nd Jul 200710:05 amRNSExtension to Credit Lines
25th Jun 20077:45 amRNSUpdate on Trading Position
25th May 20078:09 amRNSResult of AGM
21st May 20078:53 amRNSAnnual Report and Accounts
10th May 20078:39 amRNSHolding(s) in Company
8th May 20078:24 amRNSFinal Results
11th Apr 20077:00 amRNSDirectorate Change
5th Sep 20068:01 amRNSInterim Results
12th May 20067:55 amRNSSale of Shares
4th May 20067:00 amRNSDirector Appointment
3rd May 20067:00 amRNSDirector/PDMR Shareholding
2nd May 20067:00 amRNSHolding(s) in Company
26th Apr 20067:01 amRNSShareholder Transactions
26th Apr 20067:00 amRNSProposed Board Changes
13th Apr 200612:27 pmRNSAnnual Report and Accounts
3rd Apr 200611:18 amRNSFinal Results
2nd Mar 20067:47 amRNSFrthr re Production Expansion
23rd Feb 20067:00 amRNSHolding(s) in Company
2nd Feb 20067:00 amRNSDirector/PDMR Shareholding
1st Feb 20067:00 amRNSHolding(s) in Company
31st Jan 20067:23 amRNSDirector/PDMR Shareholding
30th Jan 20067:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.